Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Payables: 2021-2024

Historic Payables for Prime Medicine (PRME) over the last 4 years, with Dec 2024 value amounting to $11.4 million.

  • Prime Medicine's Payables rose 72.30% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.1 million, marking a year-over-year decrease of 6.49%. This contributed to the annual value of $11.4 million for FY2024, which is 41.90% down from last year.
  • Per Prime Medicine's latest filing, its Payables stood at $11.4 million for FY2024, which was down 41.90% from $19.5 million recorded in FY2023.
  • In the past 5 years, Prime Medicine's Payables registered a high of $19.5 million during FY2023, and its lowest value of $1.4 million during FY2021.
  • For the 3-year period, Prime Medicine's Payables averaged around $11.7 million, with its median value being $11.4 million (2024).
  • Its Payables has fluctuated over the past 5 years, first skyrocketed by 350.99% in 2023, then plummeted by 41.90% in 2024.
  • Prime Medicine's Payables (Yearly) stood at $1.4 million in 2021, then soared by 201.88% to $4.3 million in 2022, then surged by 350.99% to $19.5 million in 2023, then crashed by 41.90% to $11.4 million in 2024.